1Huitric E, Verhasseh P, Koul A, et al. Rates and mechanisms of resist- ance development in Mycobacterim tuberculosis to a novel diarylqui- nohne ATP synthase inhibitor [ J ]. Antimicrob Agents Chemother, 2010,54 (3) : 1022-1028.
2Matteelli A, Carvalho AC, Dooley KE, et al. TMC207 : the first com- pound of a new class of potent anti-tuberculosis' drugs[ J]. Future Mi- crobiol,2010,5 (6) :849-858.
3Chatterjee S, Lyle N, Mandal A, et al. GSTrl and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs [ J ]. J Clin Phann Ther,2010,35 (4) :465-470.